5 Things in ePharmacy You Need to Know This Friday 24/11/23
5 Things in ePharmacy You Need to Know This Friday 24/11/23
What’s New [🇩🇪]
Apo.com and Curalie Forge Partnership, Enhancing Digital Health Access
Health platform Apo.com, collaborates with Berlin-based eHealth company Curalie, introducing video consultations with Helios Kliniken doctors. Patients, especially those with chronic illnesses, can now seamlessly access these services through Apo.com. This partnership aims to simplify patients' lives, offering flexible digital doctor appointments alongside pharmaceutical services. Apo.com's integration of video consultations also addresses healthcare gaps in rural areas. The collaboration extends to e-prescriptions, allowing patients to redeem them on Apo.com and receive medication at home, enhancing the entire user journey.
Read more: Healthcare Marketing [Article in German]. Google Translate in English here.
What’s New [🇬🇭]
Ghana's ePharmacy Platform Faces Slow Initial Adoption
Ghana's venture into the digital pharmacy space appears to be experiencing a sluggish start, according to reports. The ePharmacy platform, aimed at enhancing healthcare accessibility, is encountering challenges in gaining widespread traction. Issues such as low user engagement and slow adoption rates are highlighted. As the nation strives to embrace digital health solutions, the article discusses the hurdles faced by the ePharmacy initiative and the potential implications for its success in transforming the country's healthcare landscape.
Read more: Tech Labari
eCommerce [🇺🇸]
Cost-Plus Drugs: an Altruistic Capitalist Venture
A Harvard Politics article delves into "Cost-Plus Drugs", an innovative, altruistic capitalist model challenging conventional pharmaceutical practices. This venture seeks fair drug pricing, transparent production costs, and equitable access. The article explores the potential of this approach to reshape the healthcare landscape, examining its implications for affordability and ethical pharmaceutical practices. In an era of rising healthcare costs, the Cost-Plus model emerges as a thought-provoking alternative, blending profit motives with a commitment to social responsibility.
Read more: Harvard Politics
Country Insights [🇬🇧]
Rich British Resort to Online Ozempic Purchases for Weight Loss
Wealthy individuals in the UK are reportedly turning to online sources to purchase the weight-loss drug Ozempic, despite its availability through the National Health Service. This unexpected trend raises questions about the reasons behind the affluent choosing online avenues and the potential implications for healthcare access and regulation. This phenomenon is explored by the press, shedding light on the dynamics driving these unconventional purchasing decisions in the context of weight management and healthcare in Britain.
Read more: Reuters
Editor’s Choice 🌍
DocMorris optimizes organization and prepares for ePrescription growth in Germany
In anticipation of the upcoming surge in electronic prescriptions in Germany, DocMorris, a leading pharmaceutical player, announces strategic organizational optimizations. The move positions the company to efficiently navigate and capitalize on the expected growth in digital prescriptions. This news sheds light on the proactive measures taken by DocMorris to align its structure with the evolving landscape of healthcare technology, emphasizing its commitment to staying ahead in the dynamic pharmaceutical sector.
Read more: DocMorris
Manufacturers & Retailers Hiring Now:
Discover actively recruiting positions in the ePharmacy Industry below:
Global Marketing Director, AstraZeneca [🇸🇪]
More info: LinkedIn
Digital Health Innovation Manager, Eli Lilly and Company [🇩🇪]
More info: LinkedIn
Digital Finance AI Analytics - Product Manager, Novartis [🇨🇿]
More info: LinkedIn
Project Manager, Perrigo [🇧🇪]
More info: LinkedIn
Business Analyst, Takeda [🇸🇰]
More info: LinkedIn
Thank you for being with us for this week! In case you found ePharmacy News interesting please do not hesitate to share it.
🕵️ Send a confidential scoop to ePharmacy News: news@epharmacynews.com